Acadia Healthcare Company Company Profile (NASDAQ:ACHC)

Acadia Healthcare Company trades on the NASDAQ under the ticker symbol "ACHC."

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) announced its earnings results on Thursday, July, 27th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.65 by $0.01. The firm earned $715.90 million during the quarter, compared to analyst estimates of $717.38 million. Acadia Healthcare Company had a net margin of 0.30% and a return on equity of 8.69%. Acadia Healthcare Company's revenue was down 5.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.73 EPS. View Acadia Healthcare Company's Earnings History.

Acadia Healthcare Company is scheduled to release their next quarterly earnings announcement on Monday, October, 30th 2017. View Earnings Estimates for Acadia Healthcare Company.

Acadia Healthcare Company issued an update on its FY17 earnings guidance on Thursday, July, 27th. The company provided earnings per share (EPS) guidance of $2.42-2.47 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.45. The company issued revenue guidance of $2.85-2.87 billion, compared to the consensus revenue estimate of $2.87 billion.

12 analysts have issued 1-year target prices for Acadia Healthcare Company's stock. Their forecasts range from $45.00 to $80.00. On average, they expect Acadia Healthcare Company's stock price to reach $59.09 in the next twelve months. View Analyst Ratings for Acadia Healthcare Company.

Here are some recent quotes from research analysts about Acadia Healthcare Company stock:

• 1. According to Zacks Investment Research, "Acadia Healthcare’s second-quarter 2017 earnings surpassed the Zacks Consensus Estimate, mainly driven by an increase in same facility revenue, patient days and revenue per patient day. The company is well positioned for long-term growth on the back of its inorganic strategies. Its latest Priory acquisition has substantially enhanced its asset base, making it the largest independent provider of mental health services in the U.K. Its mixed product portfolio has helped in intensifying business risk. The company’s strong balance sheet, with increasing cash flow is another positive. Year to date, shares of Acadia Healthcare have outperformed the industry. But the company suffers from high debt, escalating interest expenses and foreign exchange fluctuation. Substantial integration risks associated with its frequent acquisitions are major headwinds." (8/1/2017)
• 2. Cantor Fitzgerald analysts commented, "ACHC’s weak 1Q17 organic growth and a slight revenue and adjusted EBITDA miss are measured against tough comps, which continue in 2Q17, but ease in the second half, assuming no further decline in the pound. Volumes, up 5.8%, were okay in the U.S., but essentially flat overseas, and 2Q16, when organic growth was also strong, could be a tough comparison." (4/26/2017)

Acadia Healthcare Company saw a decrease in short interest in the month of August. As of August 15th, there was short interest totalling 21,282,686 shares, a decrease of 5.7% from the July 31st total of 22,575,038 shares. Based on an average daily volume of 1,020,475 shares, the days-to-cover ratio is presently 20.9 days. Approximately 25.5% of the shares of the stock are sold short.

Some companies that are related to Acadia Healthcare Company include NMC Health PLC (NMC), HealthSouth Corporation (HLS), Mednax (MD), Molina Healthcare (MOH), Chemed Corp. (CHE), Select Medical Holdings Corporation (SEM), LifePoint Health (LPNT), Udg Healthcare PLC (UDG), HMS Holdings Corp (HMSY), Tenet Healthcare Corporation (THC), China Cord Blood Corporation (CO), Community Health Systems (CYH), HealthStream (HSTM), Kindred Healthcare (KND), American Renal Associates Holdings (ARA), Georgia Healthcare Group PLC (GHG), Cambian Group PLC (CMBN) and Concord Medical Services Holdings Limited (CCM).

Acadia Healthcare Company's management team includes the folowing people:

• Joey A. Jacobs, Chairman of the Board, Chief Executive Officer
• W. Brent Turner, President
• Bruce A. Shear, Executive Vice Chairman
• David M. Duckworth, Chief Financial Officer
• Ronald Morgan Fincher, Chief Operating Officer
• Christopher L. Howard, Executive Vice President, General Counsel, Secretary
• Reeve B. Waud Jr., Lead Independent Director
• E. Perot Bissell, Independent Director
• Christopher R. Gordon, Independent Director
• Vicky B. Gregg, Independent Director

Acadia Healthcare Company's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.70%), JPMorgan Chase & Co. (7.86%), Vanguard Group Inc. (7.12%), Wells Fargo & Company MN (4.47%), FMR LLC (3.16%) and Frontier Capital Management Co. LLC (2.68%). Company insiders that own Acadia Healthcare Company stock include Brent Turner, Christopher L Howard, Danny E Carpenter, David M Duckworth, Joey A Jacobs, Randall P Goldberg, Reeve B Waud, Ronald Morgan Fincher, Scott Schwieger, Waud Capital Partners Ii, LL, Waud Capital Partners Iii, LL and William Grieco. View Institutional Ownership Trends for Acadia Healthcare Company.

Acadia Healthcare Company's stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, JPMorgan Chase & Co., Gotham Asset Management LLC, TimesSquare Capital Management LLC, Monarch Partners Asset Management LLC, Tygh Capital Management Inc., Sectoral Asset Management Inc and Great West Life Assurance Co. Can. Company insiders that have sold Acadia Healthcare Company stock in the last year include Brent Turner, Christopher L Howard, Joey A Jacobs, Randall P Goldberg, Reeve B Waud, Ronald Morgan Fincher, Scott Schwieger and William Grieco. View Insider Buying and Selling for Acadia Healthcare Company.

Acadia Healthcare Company's stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., William Blair Investment Management LLC, Janus Henderson Group PLC, State Street Corp, Dimensional Fund Advisors LP, Rice Hall James & Associates LLC, FMR LLC and Bank of New York Mellon Corp. View Insider Buying and Selling for Acadia Healthcare Company.

Shares of Acadia Healthcare Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Acadia Healthcare Company stock can currently be purchased for approximately $45.69.